Live feed
Filing
SC 13D
SC 13D0001193125-22-288740·ARS Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
ARS Pharmaceuticals Inc
Security class unavailable · CUSIP: 82835W108
Event date: 2022-11-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-288740
- Form type
- SC 13D
- Filer
- ARS Pharmaceuticals, Inc.
- CIK
- CIK 1671858
- Filed
- Nov 18, 2022
- Reporting period
- Nov 08, 2022
- Description
- Schedule 13D beneficial ownership